Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
Showing 761 - 780 results of 21,342 for search '(( significantly ((mean decrease) OR (greatest decrease)) ) OR ( significant decrease decrease ))', query time: 0.35s Refine Results
  1. 761
    Minimal data set.

    Minimal data set. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 762
    Univariate and multivariate analysis of variables associated with good and poor responders to TFESI.

    Univariate and multivariate analysis of variables associated with good and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 763
    The correlation between clinical presentations and baseline serum inflammatory cytokines before TFESI.

    The correlation between clinical presentations and baseline serum inflammatory cytokines before TFESI. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 764
    The serum concentrations of cytokines between good responders and poor responders to TFESI.

    The serum concentrations of cytokines between good responders and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 765
    Demographic data and baseline characteristics between good and poor responders to TFESI.

    Demographic data and baseline characteristics between good and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 766
    The correlation between the duration of pain symptoms and baseline serum inflammatory cytokine levels before TFESI.

    The correlation between the duration of pain symptoms and baseline serum inflammatory cytokine levels before TFESI. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 767
    Supplementary results_detailed.

    Supplementary results_detailed. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 768
    Parameter estimates of linear mixed effects models for juvenile <i>M</i>. <i>mercenaria</i>, juvenile <i>M</i>. <i>arenaria</i> and juvenile <i>A</i>. <i>islandica</i> mean shell coloration.

    Parameter estimates of linear mixed effects models for juvenile <i>M</i>. <i>mercenaria</i>, juvenile <i>M</i>. <i>arenaria</i> and juvenile <i>A</i>. <i>islandica</i> mean shell c... by Teagan McMahon (20108036)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 769
    Trust levels before and after the COVID-19 pandemic (n = 10,000).

    Trust levels before and after the COVID-19 pandemic (n = 10,000). by Alain Abi-Rizk (8549358)

    Published 2025
    Save to List
    Saved in:
  10. 770
    Baseline Characteristics of Study Participants Stratified by Sleep Duration Categories.

    Baseline Characteristics of Study Participants Stratified by Sleep Duration Categories. by Zhi Jin (3742471)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 771
    Incidence of New-Onset Cardiovascular Disease in 2018 Follow-up by Sleep Duration Groups.

    Incidence of New-Onset Cardiovascular Disease in 2018 Follow-up by Sleep Duration Groups. by Zhi Jin (3742471)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 772
    Subgroup Analysis of Sleep Duration and Cardiovascular Disease Risk in Type 2 Diabetes Patients.

    Subgroup Analysis of Sleep Duration and Cardiovascular Disease Risk in Type 2 Diabetes Patients. by Zhi Jin (3742471)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 773
    Association of Sleep Duration with Cardiovascular Disease Risk in Type 2 Diabetes Patients: Analysis Using Different Models.

    Association of Sleep Duration with Cardiovascular Disease Risk in Type 2 Diabetes Patients: Analysis Using Different Models. by Zhi Jin (3742471)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 774
    Flow Chart of Study Participant Selection.

    Flow Chart of Study Participant Selection. by Zhi Jin (3742471)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 775
    Linear relationship between sleep duration and cardiovascular disease (CVD) risk in type 2 diabetes patients.

    Linear relationship between sleep duration and cardiovascular disease (CVD) risk in type 2 diabetes patients. by Zhi Jin (3742471)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 776
    Tax1bp1-deficiency decreases the frequency of microabscess formation and lymphocyte depletion during <i>L. monocytogenes</i> infection.

    Tax1bp1-deficiency decreases the frequency of microabscess formation and lymphocyte depletion during <i>L. monocytogenes</i> infection. by Jeffrey Chin (22538086)

    Published 2025
    Save to List
    Saved in:
  17. 777
    Line graph illustrating mean food intake (in grams) at weekly intervals during the induction phase.

    Line graph illustrating mean food intake (in grams) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 778
    Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase.

    Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 779
    Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase.

    Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 780
    Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase.

    Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: